Pablo Cagnoni J.'s Insider Trades & SAST Disclosures

Pablo Cagnoni J.'s most recent trade in Incyte Corp. was a trade of 40,289 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 17, 2025.

Share

Note

This is a custom search result for pattern Pablo Cagnoni J..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Incyte Corp. High Loss High Volume	Pablo J. Cagnoni	President, R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	40,289	40,289	-		-	Employee Stock Option (right to buy)
Incyte Corp. High Loss High Volume	Pablo J. Cagnoni	President, R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2024	44,411	44,411	-		-	Employee Stock Option (right to buy)
Incyte Corp. High Loss High Volume	Pablo J. Cagnoni	President, R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2024	19,851	221,919 (0%)	0%		0	Common Stock
Incyte Corp. High Loss High Volume	Pablo J. Cagnoni	President, R&D	Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share.	15 Jul 2024	749	221,170 (0%)	0%	64.2	48,123	Common Stock
Incyte Corp. High Loss High Volume	Pablo Cagnoni J.	President, R&D	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2024	21,843	21,843	-		-	Employee Stock Option (right to buy)
Fusion Pharmaceuticals Inc Board Meeting	Pablo J. Cagnoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2022	17,000	17,000	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	Pablo J. Cagnoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2021	17,000	17,000	-		-	Stock Option (Right to Buy)
Fusion Pharmaceuticals Inc Board Meeting	Pablo J. Cagnoni	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2020	30,000	30,000	-		-	Stock Option (Right to Buy)

Showing 1 to 8 of 8 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades